Reviewing the data from the second arm of DexCom, Inc.'s Diamond study, Baird said the results are positive for Continuous Glucose Monitoring, or CGM, and modestly positive, or at least not as feared for insulin pumps.The results were inadvertently released through a poster at the tenth international conference on Advanced Technologies & Treatments for Diabetes in Paris on Wednesday. This faux pas came ahead of the official release/discussion of the results at the conference on Thursday.via